PMGC Holdings Inc. (ELAB) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$2.82

From 52W high−99.96%

Volume4872.00

Market cap$2.29M

P/E (TTM)—

P/S (TTM)3.9x

Div yield—

Key dataOct 19, 2026

Open

$2.82

From 52W high

−99.96%

Volume

4872.00

Market cap

$2.29M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

P/E (TTM)

—

RSI (14)

25.0

MomentumView details →

1D Return

+2.17%

YTD Return

−99.80%

SummaryUpdated Jun 1, 2026

PMGC Holdings Inc. (NASDAQ:ELAB) is a biopharmaceutical company founded in 2020 and based in Newport Beach, California. The company was formerly known as Elevai Labs, Inc. before changing its name to PMGC Holdings Inc. in December 2024. PMGC went public in November 2023 and focuses on developing cutting-edge aesthetic medicines and therapeutic products, with particular emphasis on addressing obesity-related challenges through innovative probiotic approaches.

Ask drillr about PMGC Holdings Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.4x

EV/Sales

−4.4x

P/S (TTM)

3.9x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

12.68%

Net Margin

−1306.28%

EBITDA Margin

−1231.39%

ROE (TTM)

−46.05%

ROA (TTM)

−21.08%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−8.34%

EPS CAGR 3Y

+94.25%

EBITDA YoY

—

MomentumView details →

1D Return

+2.17%

YTD Return

−99.80%

1Y Return

−99.96%

RSI (14)

25.0

vs 50D SMA

−44.04%

vs 200D SMA

−95.69%

Capital & dividendView details →

Debt/Equity

0.83x

Current Ratio

1.36x

Quick Ratio

1.30x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.61

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.97M

Net Income (TTM)

−15.86M

Op. CF (TTM)

—

Latest newsMore news →

PMGC Holdings completed a $100 million SPAC IPO for NorthStrive Acquisition Corp. I, which began trading on Nasdaq under the ticker NSAI.19d ago

PMGC Holdings Inc. (Nasdaq: ELAB) secured a five-year royalty stream from the sale of Elevai Skincare under an executed payment agreement with Longevity Health Holdings.32d ago

Similar companies

BioXcel Therapeutics, Inc.BTAI Onconetix, Inc.ONCO Silo Pharma, Inc.SILO BioRestorative Therapies, Inc.BRTX Lunai Bioworks Inc.LNAI CASI Pharmaceuticals, Inc.CASI Find similar companies →

Latest newsMore news →

PMGC Holdings completed a $100 million SPAC IPO for NorthStrive Acquisition Corp. I, which began trading on Nasdaq under the ticker NSAI.19d ago PMGC Holdings Inc. (Nasdaq: ELAB) secured a five-year royalty stream from the sale of Elevai Skincare under an executed payment agreement with Longevity Health Holdings.32d ago